A systematic review of manic/hypomanic and depressive switches in patients with bipolar disorder in naturalistic settings: The role of antidepressant and antipsychotic drugs

dc.contributor.authorBarbuti, Margherita
dc.contributor.authorMenculini, Giulia
dc.contributor.authorVerdolini, Norma
dc.contributor.authorPacchiarotti, Isabella
dc.contributor.authorKotzalidis, Georgios D.
dc.contributor.authorTortorella, Alfonso
dc.contributor.authorVieta i Pascual, Eduard, 1963-
dc.contributor.authorPerugi, Giulio
dc.date.accessioned2024-04-24T12:53:34Z
dc.date.available2024-04-26T05:10:16Z
dc.date.issued2023-08-01
dc.date.updated2024-04-24T12:53:39Z
dc.description.abstractThe present systematic review was aimed at critically summarizing the evidence about treatmentemergent manic/hypomanic and depressive switches during the course of bipolar disorder (BD). A systematic search of the MEDLINE, EMBASE, CINAHL, Web of Science, and PsycInfo electronic databases was conducted until March 24th , 2021, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Observational studies clearly reporting data regarding the prevalence of treatment-emergent mood switches in patients with BD were considered for inclusion. Thirty-two original studies met the inclusion criteria. In the majority of cases, manic switches were analyzed; only 3 papers investigated depressive switches in type I BD. Treatment-emergent mania/hypomania in BD subjects ranged from 17.3% to 48.8% and was more frequent with antidepressant monotherapy compared to combination treatment with mood stabilizers, especially lithium, or second-generation antipsychotics. A higher likelihood of mood switch has been reported with tricyclics and a lower rate with bupropion. Depressive switches were detected in 5-16% of type I BD subjects and were associated with first-generation antipsychotic use, the concomitant use of first- and second-generation antipsychotics, and benzodiazepines. The included studies presented considerable methodological heterogeneity, small sample sizes and comparability flaws. In conclusion, many studies, although heterogeneous and partly discordant, have been conducted on manic/hypomanic switches, whereas depressive switches during treatment with antipsychotics are poorly investigated. In BD subjects, both antidepressant and antipsychotic medications seems to play a role in the occurrence of mood switches, although the effects of different pharmacological compounds have yet to be fully investigated.
dc.format.extent72 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec735371
dc.identifier.issn0924-977X
dc.identifier.pmid37119556
dc.identifier.urihttps://hdl.handle.net/2445/210406
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.euroneuro.2023.04.013
dc.relation.ispartofEuropean Neuropsychopharmacology, 2023, vol. 73, p. 1-15
dc.relation.urihttps://doi.org/10.1016/j.euroneuro.2023.04.013
dc.rightscc-by-nc-nd (c) Elsevier B.V., 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationMedicaments
dc.subject.classificationTrastorn bipolar
dc.subject.classificationDepressió psíquica
dc.subject.classificationAntidepressius
dc.subject.otherDrugs
dc.subject.otherManic-depressive illness
dc.subject.otherMental depression
dc.subject.otherAntidepressants
dc.titleA systematic review of manic/hypomanic and depressive switches in patients with bipolar disorder in naturalistic settings: The role of antidepressant and antipsychotic drugs
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
262352.pdf
Mida:
2.42 MB
Format:
Adobe Portable Document Format